CorMedix (CRMD) Net Cash Flow (2010 - 2025)

CorMedix (CRMD) has 15 years of Net Cash Flow data on file, last reported at $96.3 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 1695.31% year-over-year to $96.3 million; the trailing twelve-month figure through Dec 2025 stood at $105.1 million (up 3528.03% YoY), and the FY2025 full-year result was $105.1 million, up 3528.03% from the prior year.
• Net Cash Flow climbed to $96.3 million in Q4 2025, from -$109.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $96.3 million in Q4 2025 to a low of -$109.9 million in Q3 2025.
• A 5-year average of $5.2 million and a median of -$4.4 million in 2021 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 8611.45% in 2023 and surged 1695.31% in 2025, its largest moves.
• Tracing CRMD's Net Cash Flow over 5 years: stood at -$13.0 million in 2021, then surged by 99.15% to -$111121.0 in 2022, then slumped by 8611.45% to -$9.7 million in 2023, then jumped by 155.44% to $5.4 million in 2024, then surged by 1695.31% to $96.3 million in 2025.
• Business Quant data shows CRMD's Net Cash Flow at $96.3 million in Q4 2025, -$109.9 million in Q3 2025, and $93.0 million in Q2 2025.